Status:

UNKNOWN

Microbial Colonization of Dairy Free Oral Probiotics

Lead Sponsor:

John Hale

Conditions:

Microbial Colonization

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

The aim of this study is to evaluate the colonization efficacy of probiotic lozenges containing dairy and dairy free probiotic Streptococcus salivarius M18, in healthy adults

Detailed Description

This is a double-blind, randomized controlled colonization pilot study with no cross over to evaluate the colonization efficacy of two different lozenges containing either dairy or dairy free probioti...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Male or Female 18y - 80y age
  • In general good health 18 - 80 years of age.
  • Practice good oral hygiene.
  • Exclusion criteria:
  • Have a history of autoimmune disease or are immunocompromised.
  • Are on concurrent antibiotic therapy or regular antibiotic use within last 1 week
  • History of allergy (e.g. dairy).

Exclusion

    Key Trial Info

    Start Date :

    June 1 2022

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    August 1 2022

    Estimated Enrollment :

    30 Patients enrolled

    Trial Details

    Trial ID

    NCT05375396

    Start Date

    June 1 2022

    End Date

    August 1 2022

    Last Update

    May 16 2022

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Blis Technologies Ltd

    Dunedin, Otago, New Zealand, 9012